Citigroup Reiterates Buy Rating on FedEx Corporation (FDX)
Rating Change Citigroup analysts reiterated a Buy rating on FedEx Corporation (NYSE:FDX) on June 24, 2026. Market Context FedEx Corporation operates in the Industrials sector. The…
Read moreReal-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Rating Change Citigroup analysts reiterated a Buy rating on FedEx Corporation (NYSE:FDX) on June 24, 2026. Market Context FedEx Corporation operates in the Industrials sector. The…
Read moreRating Change B of A Securities analysts reiterated a Buy rating on FedEx Corporation (NYSE:FDX) on June 24, 2026. Market Context FedEx Corporation operates in the Industrials…
Read moreRating Change Citigroup analysts reiterated a Buy rating on Ecolab Inc. (NYSE:ECL) on June 24, 2026. Market Context Ecolab Inc.
Read moreRating Change Stifel analysts reiterated a Buy rating on Marvell Technology, Inc. (NASDAQ:MRVL) on June 24, 2026. Market Context Marvell Technology, Inc.
Read moreRating Change Citigroup analysts reiterated a Buy rating on The Sherwin-Williams Company (NYSE:SHW) on June 24, 2026. Market Context The Sherwin-Williams Company operates in the…
Read moreRating Change HC Wainwright & Co. analysts reiterated a Buy rating on ProMIS Neurosciences, Inc. (NASDAQ:PMN) on June 24, 2026.
Read moreRating Change Cantor Fitzgerald analysts reiterated a Overweight rating on Tenax Therapeutics, Inc. (NASDAQ:TENX) on June 24, 2026. Market Context Tenax Therapeutics, Inc.
Read moreRating Change Mizuho analysts initiated coverage on Sol-Gel Technologies Ltd. (NASDAQ:SLGL) with a Outperform rating on June 24, 2026. Market Context Sol-Gel Technologies Ltd.
Read moreRating Change B. Riley Securities analysts reiterated a Buy rating on FrontView REIT, Inc. (NYSE:FVR) on June 24, 2026.
Read moreRating Change Guggenheim analysts reiterated a Buy rating on EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) on June 24, 2026. Market Context EyePoint Pharmaceuticals, Inc.
Read moreRating Change Citizens analysts reiterated a Market Outperform rating on U.S. Physical Therapy, Inc. (NYSE:USPH) on June 24, 2026.
Read moreRating Change Raymond James analysts downgraded V2X, Inc. (NYSE:VVX) from Outperform to Market Perform on June 24, 2026. Market Context V2X, Inc.
Read moreRating Change Wells Fargo analysts reiterated a Overweight rating on Sunstone Hotel Investors, Inc. (NYSE:SHO) on June 24, 2026. Market Context Sunstone Hotel Investors, Inc.
Read moreRating Change Rosenblatt analysts reiterated a Buy rating on Quantum Computing, Inc. (NASDAQ:QUBT) on June 24, 2026. Market Context Quantum Computing, Inc.
Read moreRating Change JP Morgan analysts reiterated a Overweight rating on LegalZoom.com, Inc. (NASDAQ:LZ) on June 24, 2026. Market Context LegalZoom.com, Inc.
Read moreRating Change Barclays analysts reiterated a Overweight rating on Twist Bioscience Corporation (NASDAQ:TWST) on June 24, 2026. Market Context Twist Bioscience Corporation operates…
Read moreRating Change Barrington Research analysts initiated coverage on CBIZ, Inc. (NYSE:CBZ) with a Outperform rating on June 24, 2026. Market Context CBIZ, Inc.
Read moreRating Change Citizens analysts initiated coverage on Marathon Digital Holdings, Inc. (NASDAQ:MARA) with a Market Outperform rating on June 24, 2026. Market Context Marathon…
Read moreRating Change Wells Fargo analysts reiterated a Underweight rating on KB Home (NYSE:KBH) on June 24, 2026. Market Context KB Home operates in the Consumer Cyclical sector. The…
Read moreRating Change UBS analysts reiterated a Buy rating on KB Home (NYSE:KBH) on June 24, 2026. Market Context KB Home operates in the Consumer Cyclical sector. The stock currently…
Read more